Chairman, CEO and Pres
Mr. Kenneth C. Frazier is Chairman of the Board, President, Chief Executive Officer of Merck Co., Inc. Mr. Frazier previously served as Executive Vice President and President, Global Human Health of the Company and Merck Sharp Dohme Corporationration
Age: 60 Chairman Since 2011
908 735-1500 www.merck.com
|Frazier also served as Executive Vice President and General Counsel of Merck Sharp & Dohme Corporationration . Director, Exxon Mobil Corporationrationration since 2009 and Pharmaceutical Research and Manufacturers of America since 2011. Trustee, The Pennsylvania State University and Cornerstone Christian Academy in Philadelphia, PA; Member, Board of Overseers of Weill Cornell Medical College and Graduate School of Medical Sciences, American Academy of Arts and Sciences, Council on Foreign Relations, the Council of the American Law Institute and the American Bar Association.|
The company has Return on Asset of 0.06 %
which means that on every $100 spent on asset it made $0.06 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE)
of 0.12 %
implying that it generated $0.12 on every 100 dollars invested.
The company has 26.41 B in debt with debt to equity (D/E) ratio of 0.57 which is OK given its current industry classification. Merck Co Inc has Current Ratio of 1.85 which is typical for the industry and considered as normal.
Merck & Co., Inc. offer healthcare solutions worldwide. Merck Co Inc (MRK) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 66,645 people. Merck is listed under Pharmaceutical Products category by Fama And French industry classification and specializes in Healthcare
with concentration in Pharmaceuticals And Biosciences